tiprankstipranks
Laekna, Inc. (HK:2105)
:2105
Hong Kong Market
2105
Laekna, Inc.
RESEARCH TOOLSreports

Laekna, Inc. (2105) Stock News & Sentiment

4 Followers
Laekna Advances Obesity Candidate LAE102 With Positive Phase I Data
Premium
Company Announcements
Laekna Advances Obesity Candidate LAE102 With Positive Phase I Data
27d ago
2105
Laekna Announces Positive Phase I Results for Obesity-Targeted Antibody LAE102
Premium
Company Announcements
Laekna Announces Positive Phase I Results for Obesity-Targeted Antibody LAE102
1M ago
2105
Laekna Sets March 2026 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Laekna Sets March 2026 Board Meeting to Approve 2025 Annual Results
1M ago
2105
Laekna Wins FDA Acceptance of IND for New PI3Kα Inhibitor LAE118
Premium
Company Announcements
Laekna Wins FDA Acceptance of IND for New PI3Kα Inhibitor LAE118
3M ago
2105
Laekna Doses First Subject in Phase I Trial of Metabolic Drug Candidate LAE103
Premium
Company Announcements
Laekna Doses First Subject in Phase I Trial of Metabolic Drug Candidate LAE103
3M ago
2105
Laekna Doses First Patient in Phase I Multiple-Dose Expansion Study of Obesity Drug LAE102
Premium
Company Announcements
Laekna Doses First Patient in Phase I Multiple-Dose Expansion Study of Obesity Drug LAE102
4M ago
2105
Laekna Completes Enrollment for Phase III Breast Cancer Trial
Premium
Company Announcements
Laekna Completes Enrollment for Phase III Breast Cancer Trial
4M ago
2105
More HK:2105 News >

2105 News on the Web

Soochow Securities Remains a Buy on Laekna, Inc. (2105)
TipRanks News
Neutral
Laekna, Inc. (2105) Gets a Buy from First Shanghai Securities
TipRanks News
Bullish
DBS Reaffirms Their Buy Rating on Laekna, Inc. (2105)
TipRanks News
Bullish
Laekna Advances Obesity Candidate LAE102 With Positive Phase I Data
TipRanks News
Bullish
Laekna Announces Positive Phase I Results for Obesity-Targeted Antibody LAE102
TipRanks News
Bullish
Laekna Sets March 2026 Board Meeting to Approve 2025 Annual Results
TipRanks News
Neutral
Laekna Doses First Subject in Phase I Trial of Metabolic Drug Candidate LAE103
TipRanks News
Neutral
Laekna, Inc. Partners with Qilu Pharma for Exclusive Licensing of LAE002 in China
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2105’s Media Buzz Sentiment?
Currently, no data Available
What is HK:2105’s weekly average amount of articles?
Currently, no data Available
What is HK:2105’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
STAAStaar Surgical
ALLOAllogene Therapeutics
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week